ONCO Oncology Med Inc.
Oncology Med Inc. (ONCO) is expected to report earnings on November 12, 2026, before the market open.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Oncology Med Inc.
Onconetix Inc. is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. Onconetix Inc., formerly known as Blue Water Biotech Inc., is based in CINCINNATI.
Industry
CATV Systems
Charts powered in part by Lightweight Charts™ by TradingView.